RMH Holdings (8437) Fair Value & Analysis
Healthcare · HK · Market cap HK$16.7M
Fair value as of: Jul 3, 2026
From 7 valuation models · updated 9 days ago
Price vs Fair Value (12 months)
12‑month range HK$0.1260 – HK$0.4200 · fair‑value band HK$0.0300 – HK$0.0700 · the HK$0.2500 price screens above the HK$0.0500 fair value. As of Jul 3, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
RMH Holdings (8437) currently trades at HK$0.2500, while our model-based Fair Value estimate is HK$0.0500 — implying the stock looks roughly 80.0% overvalued today. We read business quality at 57/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
Trailing-twelve-month revenue stands at HK$2.2M. Revenue declined 58.1% year over year. Net debt stands at HK$3.7M. Fundamentals as of Jul 3, 2026
Our scenario range runs from HK$0.0300 (bear case) to HK$0.0700 (bull case); at HK$0.2500, the current price sits above that range. The share trades about 46% below its 52-week high and 136% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 7% fair-value upside — at -80%, 8437 screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.
About the company
RMH Holdings Limited, an investment holding company, provides medical, dermatological, and aesthetic services and products in Singapore, Hong Kong, and the People's Republic of China. The company operates Dental Services, Trading sales, and Clinical Healthcare and Dermatological Services segments. It offers dermatology aesthetic and treatment; and dental care and dental implantation services. The company is also involved in the treatment of skin cancer and skin diseases, such as eczema, psoriasis, acne, pigmentation, adverse drug reactions, and warts; and provision of consultation, prescription, and dispensing services. In addition, it engages in the trading of health and nutritional supplement products and medical products; and offers orthodontics and implantology services. Further, the company operates franchised oral and dental clinics; and provides diagnostic and screening services, including computed tomography scanner, magnetic resonance imaging, ultrasounds, and mammography. …
Revenue & earnings trend
FY2020 – FY2024 · reported fiscal years
RMH Holdings reported revenue of HK$5.0M in FY2024 versus HK$7.8M in FY2020, a compound −10.4%/yr. Reported net income was −HK$3.5M in FY2024.
Is 8437 fairly valued? → Check now
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$97.60 | R$115.75 | +19% |
| Fresenius SE FSNUY | $11.30 | $8.61 | -24% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.76 SGD | 1.28 SGD | -54% |
| Rede D'Or São Luiz S.A RDOR3 | R$33.83 | R$46.94 | +39% |
| Tenet Healthcare Corporation THC | $162.06 | $282.55 | +74% |
| Fresenius Medical Care AG FMS | $23.70 | $45.51 | +92% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,489 | ₹2,128 | -75% |
| DaVita Inc DVAI34 | R$1,030 | R$1,096 | +7% |
| Aier Eye Hospital Group 300015 | ¥8.54 | ¥6.73 | -21% |
| Bangkok Dusit Medical Services Public Company BDUUF | $0.6400 | $0.6400 | +0% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is RMH Holdings (8437) undervalued?
What is the fair value of 8437?
What is the quality score of 8437?
What is the revenue of RMH Holdings (8437)?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Unlock the full RMH Holdings analysis — and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.